Curing Diabetes - Not With The Informational Process In Use
Wed March 8, 2017 8:35 AM|PR Newswire
EAST NORWICH, N.Y., March 8, 2017 /PRNewswire/ -- Brittle Diabetes Foundation in its search of medical literature found information of importance to all. Medical research journals publish 2,000 to 4,000 articles per day. It is estimated that a physician specializing in diabetes would have to read 19 articles/day to keep abreast. Scientists and physicians can't keep up with the papers being generated without the use of sophisticated information-flow technology.
It presently takes 17 years for a medical researcher's findings considered beneficial to patients to be incorporated into routine use by practicing physicians.
John Ioannidis M.D., whose acclaimed 2005 paper "Why most published research findings are false" continues to challenge his peers by exposing bad science. His position, recognized by the medical community, suggests that at least 50% of the information relied on by physicians is "flawed". This raises serious questions regarding the quality of research being performed and the billions in taxpayer dollars wasted.
Patients assume that medical service currently being provided is based on the latest relevant information available. Such is not the case.
The solution rests with translational medicine which is evolving to accelerate the transfer of biomedical research findings into clinical practice. It serves to bolster the "evidence-based medicine" movement presently making in-roads into medical diagnosis.
Brittle Diabetes Foundation (BDF) wonders "How can an organization, like the American Diabetes Association (ADA), claim to be seeking a cure for diabetes for the last 76 years without investing in an informational flow system that can discern relevant information while accelerating the process for incorporating research advances into clinical practice." On a Feb. 6, 2016 call with the now former VP for Communications, Dr. Jane Chiang indicated that ADA "does not have the resources to create what you're proposing" despite having raised nearly one billion dollars in the past five years.
BDF, as part of its March 2016 proposal to ADA for recognition of Brittle Type 1 Diabetes as a rare disease, again suggested the development of a high-speed information platform to accelerate data flow. Both proposals met with no response from an organization claiming to improve the lives of all those afflicted with diabetes.
In contrast, one of the first things CZI (Chan Zuckerberg's Initiative) did in its quest to cure diseases was to acquire META. Meta, a search-engine employing artificial intelligence, reads millions of research articles, selects relevant papers, sorts, and disseminates information while uncovering impactful discoveries years ahead of time. It can also be integrated into existing platforms. Once fully implemented, it will be free. If Dr. Ioannides' key factors for flawed research are combined with Meta A.I. programming, assuming they haven't already, sorting relevant papers from those considered bad science should be enhanced.
It is unlikely that the American Diabetes Association will fulfill its mission to find a cure, if it continues to follow its current operational program.
Emanuel V. Sorge Ph.D.
Brittle Diabetes Foundation